ADVFN US – Market Content Editor
-
AST SpaceMobile Shares Surge 13% Premarket Following Satellite Launch Update
AST SpaceMobile (NASDAQ:ASTS) saw its shares climb by 13% in early U.S. trading on Tuesday after the company announced a revised schedule for launching its next set of BlueBird satellites. The firm, which specializes in satellite-to-smartphone connectivity, aims to build a high-speed cellular broadband network by deploying its constellation of low-Earth-orbit BlueBird satellites. Notable investors…
-
U.S. Stocks Finish Choppy Trading Day Moderately Lower
Following the strong upward move seen in the previous week, stocks showed a lack of direction over the course of the trading session on Monday. The major averages spent the day bouncing back and forth across the unchanged line. The major averages eventually ended the day in negative territory. While the slid 200.52 points or…
-
Viatris Shares Climb Following FDA Clearance of First Generic Iron Sucrose Injection
Viatris Inc (NASDAQ:VTRS) saw its stock increase by 2.6% after the U.S. Food and Drug Administration approved its Iron Sucrose Injection, USP, marking the first generic alternative to Venofer® Injection. This intravenous iron replacement therapy is prescribed for iron deficiency anemia in both adult and pediatric patients suffering from chronic kidney disease. The product will…
-
VivoPower Shares Jump After Announcement to Acquire Ripple Labs Equity
VivoPower International PLC (NASDAQ:VVPR) saw its stock climb 9% following news of its intent to acquire shares in Ripple Labs, enhancing its strategy centered around XRP digital assets in its treasury. The company has allocated an initial $100 million to buy privately held Ripple shares after completing a two-month due diligence process. These purchases remain…
-
Amphastar Shares Rise Following FDA Approval of Generic Iron Sucrose Injection
Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock increase by 4% after the company announced that the FDA had approved its generic version of iron sucrose injection, a treatment used for iron deficiency anemia in patients with chronic kidney disease. The newly authorized medication, formerly known as AMP-002, will be offered in three dosage strengths: 50mg/2.5mL, 100mg/5mL,…
-
IO Biotech Shares Climb Following Encouraging Cancer Vaccine Trial Results
IO Biotech (NASDAQ:IOBT) stock gained 6.1% after revealing topline data from its pivotal Phase 3 trial evaluating Cylembio, an experimental cancer vaccine, combined with Merck’s (NSE:PROR) KEYTRUDA in patients with advanced melanoma. The study demonstrated clinical benefits in progression-free survival (PFS) for the combination treatment versus KEYTRUDA alone, though it narrowly fell short of statistical…
-
Nyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment
Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat moderate to severe obstructive sleep apnea (OSA). The Belgium-based medtech firm secured marketing authorization for its cutting-edge hypoglossal nerve stimulation (HGNS) device, intended for patients with an Apnea-Hypopnea Index (AHI) ranging from 15 to 65.…
-
Intel Shares Climb as CEO Gears Up for White House Meeting Amid Trump’s Call for Resignation
Intel (NASDAQ:INTC) stock edged up 3% Monday morning, recovering some of its recent losses as CEO Lip-Bu Tan prepares to meet with President Trump at the White House. This comes after Trump publicly demanded Tan’s resignation last week. The Wall Street Journal reports that Tan is scheduled to meet with Trump on Monday to address…
-
Cannabis Stocks Rally as Trump Mulls Marijuana Reclassification
Shares of Canopy Growth Corp (NASDAQ:CGC) jumped 19.2% on Monday amid reports that President Donald Trump is considering lowering marijuana’s federal classification, a move that could reshape the regulatory environment for the cannabis industry. Other leading cannabis firms also experienced significant gains, with Tilray (NASDAQ:TLRY) soaring 17.7%, Cronos Group (NASDAQ:CRON) rising 14.3%, Aurora Cannabis (NASDAQ:ACB)…
-
Cango Shares Climb Following Purchase of 50 MW Mining Facility in Georgia
Cango Inc. (NYSE:CANG) saw its stock rise 3.2% after the company disclosed it had acquired a fully operational 50 MW mining facility located in Georgia, USA, for $19.5 million in cash. This acquisition signals Cango’s strategic shift toward expanding its portfolio to include a mix of Bitcoin mining and energy infrastructure assets. Previously, the facility…